Targeting mitochondrial ClpP: structural insights and therapeutic potential of ClpP agonists in cancer therapy

Area of Science:

• Mitochondrial biology
• Oncology
• Drug discovery

Background:

• Mitochondria are vital for cellular energy and metabolism; their dysfunction is linked to diseases like cancer.
• The mitochondrial serine protease ClpP, with its cochaperone ClpX, maintains mitochondrial integrity by degrading damaged proteins.
• ClpP is increasingly recognized for its overexpression in various cancer types, positioning it as a potential therapeutic target.

Purpose of the Study:

• To review the structure, physiological role, and therapeutic potential of mitochondrial ClpP in cancer.
• To explore the mechanistic basis for using ClpP agonists as anticancer agents.
• To discuss challenges in developing selective human ClpP activators.

Main Methods:

• Literature review of current research on mitochondrial ClpP.
• Analysis of ClpP's role in cellular signaling and protein degradation.
• Examination of drug development strategies for ClpP agonists.

Main Results:

• ClpP's overexpression in cancer suggests its involvement in tumorigenesis.
• ClpP agonists show promise as a novel class of anticancer drugs.
• Developing selective small molecules targeting human ClpP presents significant challenges.

Conclusions:

• Mitochondrial ClpP represents an underexplored target for cancer therapy.
• Targeting ClpP offers a novel therapeutic avenue for cancer treatment.
• Further research is needed to overcome challenges in developing specific ClpP-activating drugs.